Skip to content

Simplivia’s portfolio includes the Chemfort™ CSTD for drug preparation. Chemfort™ is empowered by patented Toxi-Guard® technology, and supported by 20 years of leading science and peer-reviewed studies. It also includes the Chemfort™ Closed Administration product family, offering complete integration with nurse workflows and drug protocols. The addition of the Administration portfolio enables a complete vial-to-vein solution that ensures the safety of healthcare professionals when handling hazardous drugs. At the same time, drug sterility is maintained.

The entire Chemfort™ product family is designed and manufactured with a focus on safety, simplicity, and efficiency. Chemfort™ has been tested with real cytotoxic drugs for vapor containment and found compatible with all known hazardous drugs. In addition, the product family has FDA and CE approval and is ONB compliant.

Chemfort™ provides pharmacists and nurses with unmatched safety and a confident experience when handling hazardous drugs.

www.simplivia.com

 

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.